Phase II trial of capecitabine, oxaliplatin plus bevacizumab followed by bevacizumab plus erlotinib: XELOBER trial

被引：0
|
作者：
Munoz, A.
Salut, A.
Pericay, C.
Garcia, C.
Roca, J.
Duenas, R.
Rivera, F.
Alonso, V.
Alonso, M.
Falco, E.
机构：
[1] Hosp Cruces, Baracaldo, Spain
[2] Hosp Arnau Vilanova, Lleida, Spain
[3] Hosp Parc Tauli, Sabadell, Spain
[4] Hosp Gen Yague, Burgos, Spain
[5] Hosp Mutua Terrasa, Terrassa, Spain
[6] Complejo Hosp Jaen, Jaen, Spain
[7] Hosp Marques de Valdecilla, Santander, Spain
[8] Hosp Miguel Servet, Zaragoza, Spain
[9] Gen Hosp, La Rioja, Spain
[10] Hosp Sont Llazer, Palma De Mallorca, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.15078
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15078
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PHASE II STUDY OF BEVACIZUMAB plus OXALIPLATIN PLUS CAPECITABINE FOLLOWED BY BEVACIZUMAB plus ERLOTINIB AS FIRST-LINE TREATMENT IN METASTATIC COLORECTAL CANCER
    Munoz, A.
    Pericay, C.
    Llorente, B.
    Alonso, V
    Duenas, R.
    Roca, J.
    Rivera, F.
    Falco, E.
    Alvarez, I
    Salud, A.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 73 - 74
  • [2] Phase II Study of Bevacizumab, Capecitabine, and Oxaliplatin Followed by Bevacizumab Plus Erlotinib as First-Line Therapy in Metastatic Colorectal Cancer
    Munoz, Alberto
    Pericay, Caries
    Garcia-Giron, Carlos
    Alonso, Vicente
    Duenas, Rosario
    Cirera, Luis
    Rivera, Fernando
    Falco, Esther
    Alvarez Bustos, Inaki
    Salud, Antonieta
    [J]. ONCOLOGY RESEARCH, 2013, 21 (04) : 181 - 191
  • [3] Phase II study of bevacizumab (B) plus oxaliplatin (Ox) plus capecitabine (C) followed by bevacizumab (B) plus erlotinib (E) as first-line treatment in metastatic colorectal cancer (mCRC).
    Munoz, A.
    Pericay, C.
    Llorente, B.
    Alonso, V.
    Duenas, R.
    Roca, J.
    Rivera, F.
    Falco, E.
    Alvarez, I.
    Salud, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] A phase II trial of gemcitabine and erlotinib followed by ChemoProton therapy plus capecitabine and oxaliplatin for locally advanced pancreatic cancer
    Sanghvi, Samrat M.
    Coffman, Alex R.
    Hsueh, Chung-Tsen
    Kang, Joseph
    Park, Annie
    Solomon, Naveenraj L.
    Garberoglio, Carlos A.
    Reeves, Mark E.
    Slater, Jerry D.
    Yang, Gary Y.
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, : 1989 - 1996
  • [5] A phase II trial of erlotinib plus bevacizumab in patients with recurrent thymoma or thymic carcinoma
    Bedano, P. M.
    Perkins, S.
    Burns, M.
    Kessler, K.
    Nelson, R.
    Schneider, B. P.
    Risley, L.
    Dropcho, S.
    Loehrer, P. J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
    Sathornsumetee, Sith
    Desjardins, Annick
    Vredenburgh, James J.
    Rich, Jeremy N.
    Gururangan, Sridharan
    Janney, D. E.
    Friedman, Allan H.
    Friedman, Henry S.
    Reardon, David A.
    [J]. NEURO-ONCOLOGY, 2009, 11 (06) : 906 - 906
  • [7] Phase II Trial of Single-Agent Bevacizumab Followed by Bevacizumab Plus Irinotecan at Tumor Progression in Recurrent Glioblastoma
    Kreisl, Teri N.
    Kim, Lyndon
    Moore, Kraig
    Duic, Paul
    Royce, Cheryl
    Stroud, Irene
    Garren, Nancy
    Mackey, Megan
    Butman, John A.
    Camphausen, Kevin
    Park, John
    Albert, Paul S.
    Fine, Howard A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (05) : 740 - 745
  • [8] OXALIPLATIN AND CAPECITABINE (XELOX) PLUS BEVACIZUMAB (BEVA) FOR ELDERLY PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (mCRC): BOXE, A PHASE II TRIAL
    Rosati, Gerardo
    Cordio, Stefano
    Leo, Silvana
    Daniele, Bruno
    Butera, Alfredo
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : v104 - v104
  • [9] Phase II trial of bevacizumab plus erlotinib for patients with recurrent malignant gliomas: Final results.
    Sathornsumetee, S.
    Desjardins, A.
    Vredenburgh, J. J.
    McLendon, R. E.
    Marcello, J.
    Herndon, J. E.
    Norfleet, J.
    Gururangan, S.
    Friedman, H. S.
    Reardon, D. A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] A phase II trial of preoperative chemoradiation therapy plus bevacizumab and erlotinib in the treatment of localized esophageal cancer
    Meluch, A. A.
    Bendell, J. C.
    Peyton, J. D.
    Rudolph, P.
    Rubin, M. S.
    Webb, C. D.
    Greco, F. A.
    Infante, J. R.
    Burris, H. A., III
    Hainsworth, J. D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
12345